Baker Bros. Advisors Lp
Affiliations
- at Igm Biosciences Inc. (IGMS), 2025-07-02
- at Incyte Corp (INCY), 2025-07-02
- at Tscan Therapeutics Inc. (TCRX), 2025-07-02
- at Kodiak Sciences Inc. (KOD), 2025-07-02
- at Kymera Therapeutics Inc. (KYMR), 2025-07-01
- at Madrigal Pharmaceuticals Inc. (MDGL), 2025-06-24
- at Prelude Therapeutics Inc (PRLD), 2025-06-13
- at Vtv Therapeutics Inc. (VTVT), 2025-06-12
- at Kiniksa Pharmaceuticals International Plc (KNSA), 2025-06-05
- at Denali Therapeutics Inc. (DNLI), 2025-06-05
- at Acadia Pharmaceuticals Inc (ACAD), 2025-06-02
- at Beigene Ltd. (ONC), 2025-05-22
- at Immunocore Holdings Plc (IMCR), 2025-05-19
- at Dbv Technologies S.a. (DBVT), 2025-03-31
- at Replimune Group Inc. (REPL), 2025-03-07
- at Sera Prognostics Inc. (SERA), 2025-02-14
- at Bicycle Therapeutics Plc (BCYC), 2025-01-06
- at Kala Bio Inc. (KALA), 2024-12-31
- at Entrada Therapeutics Inc. (TRDA), 2024-06-26
- Director, Other at Neurogene Inc. (NGNE), 2023-12-20
- Director, Other at Seagen Inc. (SGEN), 2023-12-18
- Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2023-11-24
- Other at Atreca Inc. (BCEL), 2023-10-23
- Large Shareholder, Director at Talis Biomedical Corp (TLIS), 2023-06-13
- Director at Aeglea Biotherapeutics Inc. (AGLE), 2021-06-10
- Director at Alexion Pharmaceuticals Inc. (ALXN), 2020-05-18
- Director at Zymeworks Inc. (ZYME), 2020-05-12
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
- Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
- Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
- Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
- Large Shareholder at Invitae Corp (NVTA), 2018-03-29
- Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
- Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
- Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
- Other at Xoma Corp (XOMA), 2015-07-23
- Other at Synageva Biopharma Corp (GEVA), 2015-06-23
- Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| KYMR | $44.00 | 600,309 | $26,413,596.00 | 6,117,295 | 2025-06-30 | Filing |
| KYMR | $44.00 | 55,191 | $2,428,404.00 | 534,134 | 2025-06-30 | Filing |
| IMCR | $29.56 | 92,349 | $2,729,864.14 | 2,144,060 | 2025-03-17 | Filing |
| IMCR | $29.56 | 8,589 | $253,893.42 | 178,596 | 2025-03-17 | Filing |
| IMCR | $29.74 | 646,290 | $19,221,698.66 | 2,051,711 | 2025-03-17 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ONC | $260.00 | 671,976 | $174,713,760.00 | 8,068,411 | 2025-02-28 | Filing |
| ONC | $260.00 | 60,851 | $15,821,260.00 | 730,642 | 2025-02-28 | Filing |
| BGNE | $186.50 | 916,964 | $171,013,786.00 | 8,740,387 | 2024-12-09 | Filing |
| BGNE | $186.50 | 83,036 | $15,486,214.00 | 791,493 | 2024-12-09 | Filing |
| BGNE | $208.01 | 33,943 | $7,060,609.02 | 9,657,351 | 2024-12-09 | Filing |